Biotechnology
Vial is a biotech company that advances drug development programs into clinical trials by leveraging dramatically cheaper trials and computationally designed therapeutics. The company's mission is to reimagine drug development to cure all human diseases by rebuilding infrastructure for research and deploying technology at every step of drug discovery. Vial is developing therapeutic programs including an IL-13 x TSLP treatment for asthma, COPD, and other pulmonary indications. The company focuses on making early-stage clinical research an efficient, high-quality engine for bringing life-changing medicines to market.
Industry
Biotechnology
Company Size
51-200 employees
Founded
2020
Remote Policy
Fully Remote
Beta · Sourced from candidate reports
Be the first to share your experience with Vial.
Your reply helps other candidates know what to expect.
